Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cel-Sci Corporation Common Stock (NY:CVM)

5.110 UNCHANGED
Streaming Delayed Price Updated: 8:00 PM EDT, May 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 44
Open 5.110
Bid (Size) 5.110 (1)
Ask (Size) 6.000 (4)
Prev. Close 5.110
Today's Range 5.110 - 5.110
52wk Range 0.1800 - 6.638
Shares Outstanding 91,037,256
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga

Performance

YTD
+1131.6%
+1131.6%
1 Month
+1856.4%
+1856.4%
3 Month
+1046.3%
+1046.3%
6 Month
+692.0%
+692.0%
1 Year
+305.6%
+305.6%

More News

Read More
These stocks are moving in today's session
Via Chartmill
CEL-SCI Announces Combination of Common Stock
From CEL-SCI Corporation
Via Business Wire
CEL-SCI Reports Fiscal Second Quarter 2025 Financial Results
From CEL-SCI Corporation
Via Business Wire
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
CEL-SCI to File for Regulatory Approval of Multikine in Saudi Arabia—Pursuing Local Partnerships for Commercialization and Manufacturing to Serve Middle East and North Africa Market
From CEL-SCI Corporation
Via Business Wire
Which stocks are moving on Monday?
Via Chartmill
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
New Study in the Scientific Journal “Cancer Cell” Supports CEL-SCI’s Strategy to Seek Early Approval for Multikine in Head and Neck Cancer Based on Pre-Surgical Tumor Responses
From CEL-SCI Corporation
Via Business Wire
CEL-SCI Reports New Data: Treatment with Multikine Resulted in up to 95% Improvement in Quality of Life for Head and Neck Cancer Patients
From CEL-SCI Corporation
Via Business Wire
CEL-SCI Announces Closing of $2.5 Million Offering
From CEL-SCI Corporation
Via Business Wire
Why Harrow Shares Are Trading Higher By 23%; Here Are 20 Stocks Moving Premarket
Via Benzinga
CEL-SCI Announces Pricing of $2.5 Million Offering
From CEL-SCI Corporation
Via Business Wire
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
CEL-SCI’s Head and Neck Cancer Registration Study Protocol Clears FDA Review—in Talks with Potential Partners Interested in Commercialization of Multikine
From CEL-SCI Corporation
Via Business Wire
Journal of the American Medical Association (JAMA) Study Provides Further Evidence that CEL-SCI’s Multikine Can Treat Unmet Need in ~70% of Head and Neck Patients Based on PD-L1 Expression
From CEL-SCI Corporation
Via Business Wire
Stay updated with the stocks that are on the move in today's pre-market session.
Via Chartmill
CEL-SCI to Initiate Multikine Confirmatory Phase 3 Cancer Trial
From CEL-SCI Corporation
Via Business Wire
CEL-SCI Reports Fiscal Q1 2025 Financial Results: Multikine Shows Pre-Surgical Tumor Elimination and Regression in Just 3 Weeks
From CEL-SCI Corporation
Via Business Wire
CEL-SCI Reports Fiscal 2024 Results: Set to Commence Confirmatory Study That Could Bring New Standard of Care to Head & Neck Cancer
From CEL-SCI Corporation
Via Business Wire
CEL-SCI Announces Closing of $5 Million Offering
From CEL-SCI Corporation
Via Business Wire
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Nasdaq Down Over 100 Points; US Pending Home Sales Increase In November
Via Benzinga

Frequently Asked Questions

Is Cel-Sci Corporation Common Stock publicly traded?
Yes, Cel-Sci Corporation Common Stock is publicly traded.
What exchange does Cel-Sci Corporation Common Stock trade on?
Cel-Sci Corporation Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Cel-Sci Corporation Common Stock?
The ticker symbol for Cel-Sci Corporation Common Stock is CVM on the New York Stock Exchange
What is the current price of Cel-Sci Corporation Common Stock?
The current price of Cel-Sci Corporation Common Stock is 5.110
When was Cel-Sci Corporation Common Stock last traded?
The last trade of Cel-Sci Corporation Common Stock was at 05/20/25 08:00 PM ET
What is the market capitalization of Cel-Sci Corporation Common Stock?
The market capitalization of Cel-Sci Corporation Common Stock is 465.20M
How many shares of Cel-Sci Corporation Common Stock are outstanding?
Cel-Sci Corporation Common Stock has 465M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.